Insider Transactions in Q1 2025 at Treace Medical Concepts, Inc. (TMCI)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2025
|
Mark Hair Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
187,500
+25.53%
|
-
|
|
Jan 22
2025
|
John T. Treace Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
225,000
+3.23%
|
-
|
|
Jan 22
2025
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
BUY
Grant, award, or other acquisition
|
Direct |
127,500
+18.21%
|
-
|
|
Jan 22
2025
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140,625
+27.76%
|
-
|
|
Jan 22
2025
|
Aaron Berutti SVP, Sales |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+26.08%
|
-
|
|
Jan 10
2025
|
John T. Treace Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,905
-0.18%
|
-
|
|
Jan 10
2025
|
Aaron Berutti SVP, Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
4,821
-2.91%
|
-
|
|
Jan 10
2025
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
SELL
Payment of exercise price or tax liability
|
Direct |
4,544
-1.01%
|
-
|
|
Jan 10
2025
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,821
-2.1%
|
-
|
|
Jan 10
2025
|
Mark Hair Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,594
-2.34%
|
-
|